Monticelli, M.; Liguori, L.; Allocca, M.; Andreotti, G.; Cubellis, M.V.
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG. Int. J. Mol. Sci. 2019, 20, 4164.
https://doi.org/10.3390/ijms20174164
AMA Style
Monticelli M, Liguori L, Allocca M, Andreotti G, Cubellis MV.
β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG. International Journal of Molecular Sciences. 2019; 20(17):4164.
https://doi.org/10.3390/ijms20174164
Chicago/Turabian Style
Monticelli, Maria, Ludovica Liguori, Mariateresa Allocca, Giuseppina Andreotti, and Maria Vittoria Cubellis.
2019. "β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG" International Journal of Molecular Sciences 20, no. 17: 4164.
https://doi.org/10.3390/ijms20174164
APA Style
Monticelli, M., Liguori, L., Allocca, M., Andreotti, G., & Cubellis, M. V.
(2019). β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG. International Journal of Molecular Sciences, 20(17), 4164.
https://doi.org/10.3390/ijms20174164
